Abstract
Purpose
The purposes of this study are to develop and validate new diagnostic criteria for acute retinal necrosis (ARN) based on the ocular findings, clinical course, and virologic testing of intraocular fluids.
Subjects and methods
The Japanese ARN Study Group, comprising 8 uveitis specialists and 1 statistician, was formed to develop new diagnostic criteria for ARN. The criteria used a combination of clinical features consistent with ARN including 6 early-stage ocular findings ([1a] anterior chamber cells or mutton-fat keratic precipitates; [1b] yellow-white lesion(s) in the peripheral retina [granular or patchy in the early stage, then gradually merging]; [1c] retinal arteritis; [1d] hyperemia of the optic disc; [1e] inflammatory vitreous opacities; and [1f] elevated intraocular pressure), 5 clinical courses ([2a] rapid expansion of the retinal lesion(s) circumferentially, [2b] development of retinal breaks or retinal detachment, [2c] retinal vascular occlusion, [2d] optic atrophy, and [2e] response to antiviral agents), and the results of virologic testing of intraocular fluids by means of either polymerase chain reaction or the Goldmann-Witmer coefficient for herpes simplex virus or varicella zoster virus. Various combinations of findings were analyzed to maximize the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The criteria were then used to retrospectively analyze patients who had been diagnosed as having ARN or control uveitis. Patients were followed at 1 of 7 tertiary uveitis clinics between 2009 and 2011.
Results
Analysis of the data allowed delineation of 2 levels of diagnosis: “virus-confirmed ARN” (defined as the presence of both early-stage ocular findings 1a and 1b, the presence of any 1 of the 5 clinical courses, and a positive virologic test result) and “virus-unconfirmed ARN” (defined as the presence of 4 of 6 early-stage ocular findings including 1a and 1b, presence of any 2 of the 5 clinical courses, and a negative virologic test result, or when virologic testing had not been performed). The new diagnostic criteria were applied to 45 patients with ARN and 409 patients with control uveitis, resulting in a sensitivity of 0.89, a specificity of 1.00, a PPV of 1.00, and an NPV of 0.99.
Conclusions
New diagnostic criteria for ARN were developed and found to achieve high statistical values.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Urayama A, Yamada N, Sasaki T. Unilateral acute uveitis with retinal periarteritis and detachment [in Japanese]. Rinsho Ganka. 1971;25:607–19.
Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663–7.
Usui Y, Goto H. Overview and diagnosis of acute retinal necrosis syndrome. Semin Ophthalmol. 2008;23:275–83.
Wong RW, Jumper JM, McDonald HR, Johnson RN, Fu A, Lujan BJ, et al. Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol. 2013;97:545–52.
Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120:1761–8.
Sugita S, Shimizu N, Watanabe K, Mizukami M, Morio T, Sugamoto Y, et al. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol. 2008;92:928–32.
Sugita S, Ogawa M, Inoue S, Shimizu N, Mochizuki M. Diagnosis of ocular toxoplasmosis by two polymerase chain reaction (PCR) examinations: qualitative multiplex and quantitative real-time. Jpn J Ophthalmol. 2011;55:495–501.
Sugita S, Shimizu N, Kawaguchi T, Akao N, Morio T, Mochizuki M. Identification of human herpesvirus 6 in a patient with severe unilateral panuveitis. Arch Ophthalmol. 2007;125:1426–7.
Sugita S, Shimizu N, Watanabe K, Ogawa M, Maruyama K, Usui N, et al. Virological analysis in patients with human herpes virus 6-associated ocular inflammatory disorders. Invest Ophthalmol Vis Sci. 2012;53:4692–8.
Balansard B, Bodaghi B, Cassoux N, Fardeau C, Romand S, Rozenberg F, et al. Necrotising retinopathies simulating acute retinal necrosis syndrome. Br J Ophthalmol. 2005;89:96–101.
Iwahashi-Shima C, Azumi A, Ohguro N, Okada AA, Kaburaki T, Goto H, et al. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013;57:98–103.
Ishida T, Sugamoto Y, Sugita S, Mochizuki M. Prophylactic vitrectomy for acute retinal necrosis. Jpn J Ophthalmol. 2009;53:486–9.
Watanabe T, Miki D, Okada AA, Hirakata A. Treatment results for acute retinal necrosis. Nihon Ganka Gakkai Zasshi. 2011;115:7–12.
Acknowledgments
We thank Dr. Norio Usui for his thoughtful comments and discussions. This study was supported by a Health and Labour Sciences Research Grant for research on rare and intractable diseases from the Ministry of Health, Labour and Welfare of Japan.
Conflicts of interest
H. Takase, None; A. A. Okada, None; H. Goto, None; N. Mizuki, None; K. Namba, None; N. Ohguro, None; K.-H. Sonoda, None; M. Tomita, None; H. Keino, None; T. Kezuka, None; R. Kubono, None; K. Mizuuchi, None; E. Shibuya, None; H. Takahashi, None; R. Yanai, None; M. Mochizuki, None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takase, H., Okada, A.A., Goto, H. et al. Development and validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophthalmol 59, 14–20 (2015). https://doi.org/10.1007/s10384-014-0362-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-014-0362-0